
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Press Release and Management Discussion & Analysis for the First Quarter ended 30th June 2024".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 14, 2024, titled "Press Release and Management Discussion & Analysis for the First Quarter ended 30th June 2024".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals